SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
帅气成仁
Lv2
200 积分
2024-06-01 加入
最近求助
最近应助
互助留言
Improved pathologic complete response rates for triple-negative breast cancer in the I-SPY2 Trial
1小时前
已完结
VP7-2021: KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC
1小时前
已完结
Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2
1小时前
已关闭
LncRNA FAISL Inhibits Calpain 2‐Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer
28天前
已完结
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
29天前
已完结
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy
1个月前
已完结
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer
1个月前
已完结
Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells
1个月前
已完结
A blueprint for tumor-infiltrating B cells across human cancers
1个月前
已完结
B cells, plasma cells and antibody repertoires in the tumour microenvironment
1个月前
已完结
没有进行任何应助
已找到【积分已退回】
1小时前
感谢,速度真快,帮大忙了
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论